Kaken Pharmaceutical Co., Ltd.
No trades
Price target
4,400.000.000.00%
The 3 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 3 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
4521 EPS for the last quarter is 10.71 JPY despite the estimation of 24.79 JPY. In the next quarter EPS is expected to reach 47.07 JPY. Track more of Kaken Pharmaceutical Co., Ltd. financials and stay on top of what is up with the company.
In the next quarter Kaken Pharmaceutical Co., Ltd. revenue is expected to reach 20.49 B JPY. Check out Kaken Pharmaceutical Co., Ltd. revenue and earnings and make informed decisions.
According to analysts, 4521 price target is 4,400.00 JPY with a max estimate of 5,400.00 JPY and a min estimate of 3,600.00 JPY. Check if this forecast comes true in a year, meanwhile watch Kaken Pharmaceutical Co., Ltd. stock price chart and keep track of the current situation with 4521 news and stock market news.